X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pharmacology & pharmacy (949) 949
index medicus (878) 878
animals (636) 636
beta-cyclodextrin (629) 629
humans (572) 572
solubility (474) 474
cyclodextrins (469) 469
beta-cyclodextrins - chemistry (420) 420
cyclodextrin (372) 372
2-hydroxypropyl-beta-cyclodextrin (346) 346
male (303) 303
cyclodextrins - chemistry (277) 277
beta-cyclodextrins (259) 259
chemistry, medicinal (255) 255
mice (230) 230
chemistry, multidisciplinary (222) 222
drug delivery systems (211) 211
rats (208) 208
hydroxypropyl-beta-cyclodextrin (204) 204
nanoparticles (195) 195
drugs (188) 188
female (181) 181
in-vitro (176) 176
chemistry, pharmaceutical (170) 170
inclusion complex (160) 160
bioavailability (157) 157
inclusion complexes (154) 154
drug carriers - chemistry (150) 150
delivery (135) 135
drug-delivery (134) 134
beta-cyclodextrins - pharmacology (133) 133
β-cyclodextrin (133) 133
drug stability (132) 132
biological availability (130) 130
complexation (125) 125
calorimetry, differential scanning (123) 123
particle size (122) 122
excipients - chemistry (117) 117
administration, oral (114) 114
cholesterol (109) 109
derivatives (108) 108
dissolution (108) 108
stability (108) 108
drug delivery (107) 107
pharmaceutical applications (104) 104
pharmacokinetics (104) 104
cell line, tumor (103) 103
formulation (101) 101
hydrogen-ion concentration (101) 101
biochemistry & molecular biology (97) 97
chemistry, pharmaceutical - methods (96) 96
x-ray diffraction (96) 96
release (95) 95
cancer (94) 94
nanoparticles - chemistry (93) 93
analysis (89) 89
beta-cyclodextrins - administration & dosage (88) 88
medicine (88) 88
permeability (88) 88
pharmacy (87) 87
spectroscopy, fourier transform infrared (85) 85
cyclodextrins - pharmacology (82) 82
beta-cyclodextrins - therapeutic use (81) 81
chemistry (80) 80
polymers (80) 80
article (79) 79
chemistry, analytical (76) 76
kinetics (76) 76
research (76) 76
drug compounding (75) 75
rats, wistar (75) 75
drug carriers (73) 73
lipids (73) 73
multidisciplinary sciences (72) 72
absorption (71) 71
rabbits (71) 71
solubilization (70) 70
dextrins (69) 69
nanoscience & nanotechnology (69) 69
vehicles (69) 69
cell survival - drug effects (68) 68
rats, sprague-dawley (68) 68
systems (68) 68
polymers - chemistry (67) 67
formulations (66) 66
magnetic resonance spectroscopy (65) 65
research article (65) 65
proteins (63) 63
apoptosis (61) 61
alpha-cyclodextrin (60) 60
chromatography, high pressure liquid (59) 59
dose-response relationship, drug (59) 59
drug (59) 59
excipients (59) 59
mice, inbred balb c (59) 59
tablets (58) 58
disease models, animal (57) 57
usage (57) 57
pharmacology/toxicology (56) 56
hydroxypropyl-β-cyclodextrin (55) 55
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1651) 1651
Japanese (5) 5
Italian (4) 4
Spanish (4) 4
Chinese (3) 3
French (2) 2
German (2) 2
Czech (1) 1
Hungarian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biomaterials, ISSN 0142-9612, 2016, Volume 101, pp. 217 - 228
Abstract Although considered promising materials for assisting organ regeneration, few hydrogels meet the stringent requirements of clinical translation on the... 
Advanced Basic Science | Dentistry | Supramolecular hydrogel | Biomaterial carrier | Host-guest complexation | Drug delivery | Tissue regeneration | DEXAMETHASONE | DESIGN | MATERIALS SCIENCE, BIOMATERIALS | ACID | RECOGNITION | ENGINEERING, BIOMEDICAL | OSTEOGENESIS | RELEASE | INFLAMMATION | BETA-CYCLODEXTRIN | CULTURES | Acrylates - therapeutic use | Biocompatible Materials - chemistry | Humans | Male | Drug Delivery Systems | Swine | Hydrogels - administration & dosage | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Cell Differentiation | Gelatin - chemistry | Tensile Strength | Cell Line | Dexamethasone - administration & dosage | Gelatin - administration & dosage | Acrylates - chemistry | Rats, Sprague-Dawley | Dexamethasone - therapeutic use | Injections | Animals | beta-Cyclodextrins - administration & dosage | beta-Cyclodextrins - chemistry | Tissue Adhesions - therapy | Mice, Nude | beta-Cyclodextrins - therapeutic use | Gelatin - therapeutic use | Biocompatible Materials - administration & dosage | Biocompatible Materials - therapeutic use | Hydrogels - therapeutic use | Hydrogels - chemistry | Crosslinked polymers | Cyclodextrins | Biological products | Cell differentiation | Biomedical engineering | Drugs | Drug delivery systems | Vehicles | Surgical implants | Biomedical materials | Hydrogels | Crosslinking | Infiltration | Gelatins | Biomaterials
Journal Article
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 06/2017, Volume 255, pp. 154 - 163
The development of new hetero-nanostructures for multifunctional applications in cancer therapy has attracted widespread attention. In this work, we put... 
Cellulose nanocrystal | Gold nanorod | Photoacoustic imaging | CD-PGEA | Combined therapy | DRUG | CELLS | DELIVERY-SYSTEMS | NANORODS | THERANOSTIC PLATFORM | CHEMISTRY, MULTIDISCIPLINARY | GLIOBLASTOMA | IN-VIVO | SILICA NANOPARTICLES | PHARMACOLOGY & PHARMACY | BIOMEDICAL APPLICATIONS | GENE TRANSFECTION | Polyamines - administration & dosage | Gold - administration & dosage | Cellulose - therapeutic use | DNA - therapeutic use | Polyamines - therapeutic use | Green Fluorescent Proteins - genetics | Methacrylates - chemistry | Cellulose - administration & dosage | Photoacoustic Techniques | Tumor Suppressor Protein p53 - genetics | Methacrylates - therapeutic use | Cellulose - chemistry | Hydroxyl Radical - therapeutic use | Neoplasms - therapy | Hydroxyl Radical - chemistry | Female | Nanostructures - therapeutic use | Gold - chemistry | Cell Survival - drug effects | Polyamines - chemistry | Methacrylates - administration & dosage | DNA - administration & dosage | Rats | Combined Modality Therapy | Neoplasms - drug therapy | Phototherapy | Hydroxyl Radical - administration & dosage | Animals | beta-Cyclodextrins - administration & dosage | beta-Cyclodextrins - chemistry | Mice, Nude | Nanostructures - administration & dosage | beta-Cyclodextrins - therapeutic use | Cell Line, Tumor | Gold - therapeutic use | Nanostructures - chemistry | Mice, Inbred BALB C | Antimitotic agents | Care and treatment | Hydroxides | Cellulose | Cyclodextrins | Antineoplastic agents | Health aspects | Cancer | Ethanolamines | Index Medicus
Journal Article
FEBS Letters, ISSN 0014-5793, 12/2015, Volume 589, Issue 24, pp. 4097 - 4105
We found that targeting cholesterol with beta-cyclodextrin (bCD) and its derivatives disrupted signal transduction between PI3K and AKT, attenuating AKT... 
Beta-cyclodextrin | Receptor tyrosine kinase | AKT | Pro-survival signal | 2-Deoxyglucose | Phosphoinositide 3-kinase | Mitochondria | Epidermal growth factor | Pancreatic cancer | Cancer therapy | Bcl2 | TNF-related apoptosis-inducing ligand | ABT-263 | Insulin-like growth factor 1 | Cancer | Apoptosis | Mcl1 | ACTIVATION | KERATINOCYTES | CELL BIOLOGY | INHIBITION | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHALLENGES | BIOPHYSICS | DISEASE | 2-Hydroxypropyl-beta-cyclodextrin | Neoplasms - metabolism | Apoptosis - drug effects | Humans | Antineoplastic Agents - therapeutic use | Antimetabolites - therapeutic use | beta-Cyclodextrins - pharmacology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Deoxyglucose - therapeutic use | Deoxyglucose - pharmacology | Antineoplastic Agents - pharmacology | Antimetabolites - pharmacology | Aniline Compounds - pharmacology | Specific Pathogen-Free Organisms | Mice, SCID | Sulfonamides - pharmacology | Apoptosis Regulatory Proteins - metabolism | Neoplasms - drug therapy | Drug Synergism | Xenograft Model Antitumor Assays | Animals | Anticholesteremic Agents - therapeutic use | Sulfonamides - therapeutic use | Tumor Burden - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | beta-Cyclodextrins - therapeutic use | Apoptosis Regulatory Proteins - antagonists & inhibitors | Cell Line, Tumor | Mice, Inbred NOD | Aniline Compounds - therapeutic use | Neoplasms - pathology | Anticholesteremic Agents - pharmacology | Crosses, Genetic
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 08/2016, Volume 235, pp. 48 - 62
Journal Article
Journal Article